TODAY2 Phase 1 Immediate Post-Intervention Observational Follow-up Study

Completed

Conditions studied: Diabetes Mellitus Type 2 in Obese

In brief

The purpose of this study is to continue to follow participants in the TODAY clinical trial as they transition to non-blinded, non-randomized standard diabetes care and management with monitoring and follow-up for up to 24 months (phase 1), during which time the TODAY data are analyzed and findings interpreted to develop a long-term observational protocol (phase 2). Data are collected during phase 1 for descriptive purposes; there is no primary hypothesis.

Key facts

Study ID
NCT01364350
Run by
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
People needed
550
Starts
2011-03-01
Expected to finish
2014-02-01
Last updated by the study team
2021-08-04

Who can join

Age: 12 and older, up to 24. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.